Lifeway Foods reports record weekly sales of $5.5 million

MORTON GROVE, Ill. - Lifeway Foods, Inc. (NASDAQ:LWAY), a supplier of kefir and fermented probiotic products, announced Tuesday it achieved over $5.5 million in gross sales for the week ending July 13, 2025, representing a 66% increase from the same period last year. This strong performance aligns with the company’s broader growth trajectory, having achieved a 12.8% revenue increase over the last twelve months to $188.3 million. According to InvestingPro data, the company maintains excellent financial health with a "GREAT" overall score.

The company, which specializes in fermented dairy products, described this as a milestone achievement in its press release statement.

Lifeway Foods also announced it will report its second quarter 2025 financial results on August 12, 2025, before market hours. A pre-recorded conference call with Julie Smolyanksy, the company’s President and Chief Executive Officer, will be made available through the investor relations section of Lifeway’s website upon release of the results.

The Illinois-based company produces kefir, a fermented probiotic beverage, along with various cheeses and products for children. Lifeway’s products are currently sold across the United States and in several international markets including Mexico, Ireland, South Africa, United Arab Emirates, and France.

Lifeway Foods trades on the Nasdaq exchange under the ticker symbol LWAY. The company noted in its statement that it has previously been recognized as one of Forbes’ Best Small Companies.

In other recent news, Lifeway Foods reported a 10.7% increase in net sales for the first two months of the second quarter, reaching $37.6 million compared to the same period last year. The company anticipates second-quarter net sales to be between $52 million and $56 million, highlighting continued growth in its distribution network. Lifeway Foods also announced that its products would be available in major retail chains, including Amazon Fresh, BJ’s Wholesale Club, CVS, and others, expanding its market reach. In a separate development, Edward and Ludmila Smolyansky, who hold significant voting shares, are advancing a consent solicitation to remove the current board, citing disagreements over a potential acquisition offer from Danone. Lifeway Foods urged shareholders to disregard this solicitation, labeling it legally deficient. The company highlighted its strategic success, noting a 788% return over five years and approximately 100% revenue growth from fiscal year 2019 to 2024. Additionally, Lifeway Foods’ Q1 2025 earnings met analysts’ expectations with an EPS of $0.23, though revenue fell short of forecasts at $46.09 million. Despite these challenges, Lifeway Foods continues to emphasize its leadership in the kefir market and its expansion into new product lines.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.